Current and Novel Antiplatelet Therapies for the Treatment of Cardiovascular Diseases

Current and Novel Antiplatelet Therapies for the Treatment of Cardiovascular Diseases

Over the last decades, antiplatelet agents, mainly aspirin and P2Y<sub>12</sub> receptor antagonists, have significantly reduced morbidity and mortality associated with arterial thrombosis. Their pharmacological characteristics, including pharmacokinetic/pharmacodynamics profiles, have b...

Full description

Bibliographic Details
Main Authors: Georges Jourdi, Marie Lordkipanidzé, Aurélien Philippe, Christilla Bachelot-Loza, Pascale Gaussem
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:International Journal of Molecular Sciences
Subjects:
acute coronary syndrome
aspirin
atherothrombosis
bleeding
cardiovascular disease
dual antiplatelet therapy
Online Access:https://www.mdpi.com/1422-0067/22/23/13079

Internet

https://www.mdpi.com/1422-0067/22/23/13079

Similar Items